Сінгапур - англійська - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - amlodipine besilate 13.870mg eqv amlodipine; telmisartan - tablet - 10 mg - amlodipine besilate 13.870mg eqv amlodipine 10 mg; telmisartan 80.000mg

Сінгапур - англійська - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - amlodipine besilate 6.935mg eqv amlodipine; telmisartan - tablet - 5 mg - amlodipine besilate 6.935mg eqv amlodipine 5 mg; telmisartan 80.000 mg

Сінгапур - англійська - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - ciclosporin - capsule, liquid filled - 10.0mg - ciclosporin 10.0mg

Сінгапур - англійська - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - ciclosporin - injection - 50.0mg/ml - ciclosporin 50.0mg/ml

Ізраїль - англійська - Ministry of Health

j-c health care ltd - itraconazole - solution - itraconazole 10 mg/ml - itraconazole - itraconazole - sporanox oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis. prevention of fungal infection during neutropenia of immunodeficient patients.

Європейський Союз - англійська - EMA (European Medicines Agency)

sanofi winthrop industrie - irbesartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type-2 diabetes mellitus as part of an antihypertensive medicinal-product regimen.

Європейський Союз - англійська - EMA (European Medicines Agency)

sanofi winthrop industrie - irbesartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type-2 diabetes mellitus as part of an antihypertensive medicinal product regimen.

Європейський Союз - англійська - EMA (European Medicines Agency)

novartis europharm limited - sacubitril, valsartan - heart failure - angiotensin ii antagonists, other combinations, agents acting on the renin-angiotensin system - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction.adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Європейський Союз - англійська - EMA (European Medicines Agency)

novartis europharm limited - sacubitril, valsartan - heart failure - agents acting on the renin-angiotensin system - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5.1).adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.1).

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - hydrochlorothiazide,irbesartan -